Iman Hamdan

Iman Hamdan

Auto-generated profile, based on publicly available information

Iman Hamdan

Pharmacy Department, School of Pharmacy, Al-Zaytoonah University of Jordan , Amman 11733

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ITIsmaiel Tekko
Ismaiel Tekko
GCGaoyun Chen
Gaoyun Chen
Juan Dominguez-RoblesJuan Dominguez-Robles
Juan Dominguez-Robles
RTRaghu Raj Singh Thakur
Raghu Raj Singh Thakur
IHIman M.N. Hamdan
Iman M.N. Hamdan
Ryan DonnellyRyan Donnelly
Ryan Donnelly

10 January 2024 in Pharmacia
Verified
Journal Article
Open access
PDF file
IHIman Hamdan
Iman Hamdan
The skin offers a route of administration with numerous advantages. However, one of the major limitations of this route is the limited number of drugs that possess the ideal physicochemical properties to passively diffuse through the skin barrier. Today, microneedle (MN) technology proved to be superior in the field of drug delivery. MN arrays are devices that consist of micron-sized projections which pierce the stratum corneum (SC), the main barrier for drug delivery across the skin. MN technology has the potential to provide a localised drug delivery with minimal toxicity and expand the range of drugs for transdermal and intradermal delivery. In this comprehensive review, MN technology was thoroughly discussed. Meeting regulatory standards and large-scale production is essential to advance MN technology into a cost-effectiveness commercial scale.

8 November 2019 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
MSMohammed Rohi Sanoufi
Mohammed Rohi Sanoufi
AAAhmad Aljaberi
Ahmad Aljaberi
IHIman Hamdan
Iman Hamdan
NANizar Al-Zoubi
Nizar Al-Zoubi
The effect of formulation and processing parameters on processability and release from hot-melt extrusion (HME)-based matrices appears to be API and polymer dependent. Accordingly, the aim of this work was to design an extended-release formulation of diclofenac sodium by using HME technique and design of experiment (DoE). The extrudates were prepared using a vertical lab-scale single screw extruder. A D-optimal design with 16 formulations was employed to evaluate and model the effect of diclofenac sodium, ethyl cellulose and Natrosol L levels on the release profile. The percentage of drug release at 2, 4, 8 and 16 hrs were the dependent variables. The formulation factors that affect drug release were identified and satisfactorily modeled. The goodness of fit (R2) and goodness of prediction (Q2) parameters obtained for release responses were 0.913 and 0.682 at 2 hrs, 0.946 and 0.67 at 4 hrs, 0.942 and 0.658 at 8 hrs, and 0.892 and 0.673 at 16 hrs, respectively. The design space of optimal fractions of ethyl cellulose and Natrosol L at various drug levels was successfully constructed by response surface methodology. In conclusion, the DoE approach helped to identify and quantify formulation variables that affect the release of diclofenac sodium from HME-based formulation.

5 September 2022 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
IHIman M.N. Hamdan
Iman M.N. Hamdan
ITIsmaiel A. Tekko
Ismaiel A. Tekko
SBSteven E.J. Bell
Steven E.J. Bell

1 March 2017 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
IHI.M. Hamdan
I.M. Hamdan
RDR.F. Donnelly
R.F. Donnelly

17 October 2025 in Journal of Pharmaceutical Health Services Research
Verified
Journal Article
Closed access
IHIman M N Hamdan
Iman M N Hamdan
EAEnas Alkhader
Enas Alkhader
Objectives: Telemedicine is a fast-growing branch of medicine mainly in the last decade. The main goal of telemedicine services is to sustain the capacity and ensure access to medical services for all patients, without jeopardizing the safety of the healthcare providers nor the patients. Along with the benefits that telemedicine system offers, still there are many barriers to its adoption. The aim of the current study was to demonstrate barriers to adopt telemedicine in Jordan from the perspective of healthcare providers. Methods: The method employed was a questionnaire-based survey, which piloted and tested for validity and reliability. A voluntary random sampling approach was employed. A total of 425 responses were collected. The inclusion criteria were healthcare professionals with age of 22 years and above, and willing to participate in the survey. Participants were asked to fill in an online survey and data attained were treated confidentially. Comparison and descriptive statistics were used to report the results. Key findings: The financial, information technology and technology, awareness-related, and legal barriers had a significant linear correlation with telemedicine adoption. The overall Pearson’s correlation was strong (0.32–0.42). The higher significance was assigned to the awareness-related barrier with a t-value of (5.65). Conclusions: Telemedicine is relatively a new concept in Jordan, hence, there are still hurdles and critics. The current study indicated that the digitalization of our health sector is limited by legal, financial, technological, and awareness-related barriers. The awareness-related barrier was identified as the most critical barrier.